WT1 and neoplasm: In cancers such as breast cancer, non-small cell lung cancer, and Kaposi’s sarcoma, aberrant WT1 expression has been linked to chromatin remodeling, immune evasion, and altered tumor microenvironment dynamics [29,30,31].